Advertisement

Topics

Merck-Aktie: Abwarten!

09:53 EDT 13 Jun 2018 | FinanzNachrichten

Kulmbach (www.aktiencheck.de) - Merck-Aktienanalyse von "Der Aktionär": Marion Schlegel, Redakteurin des Anlegermagazins "Der Aktionär", nimmt in einer aktuellen Aktienanalyse die Aktie des Chemie-...

Original Article: Merck-Aktie: Abwarten!

NEXT ARTICLE

More From BioPortfolio on "Merck-Aktie: Abwarten!"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...